Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:14104/feed
Other Conditions
Vol. 2, Issue 2, 2015July 15, 2015 EDT

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

Mike Durkin, Jacqueline Pesa, Jessica Lopatto, Rachel Halpern, Damon Van Voorhis, Stephanie Korrer,
oxycodone crtapentadol erresource usehealth care costschronic pain
Copyright Logoccby-4.0 • https://doi.org/10.36469/9905
Photo by Simone van der Koelen on Unsplash
JHEOR
1.
Durkin M, Pesa J, Lopatto J, Halpern R, Van Voorhis D, Korrer S. Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR. JHEOR. 2015;2(2):221-232. doi:10.36469/​9905
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system